We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.69B
AUM Growth
+$214M
Cap. Flow
+$71M
Cap. Flow %
2.64%
Top 10 Hldgs %
36.8%
Holding
3,484
New
257
Increased
1,490
Reduced
872
Closed
231

Sector Composition

Rank Sector Weight
1 Technology 16.83%
2 Financials 7.22%
3 Healthcare 6.35%
4 Consumer Discretionary 5.57%
5 Communication Services 4.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKTS
3326
DELISTED
Akoustis Technologies Inc
AKTS
$0 ﹤0.01%
30
-5
-14% -$37
AXNX
3327
DELISTED
Axonics, Inc. Common Stock
AXNX
$0 ﹤0.01%
5
+1
+25% +$61
STER
3328
DELISTED
Sterling Check Corp. Common Stock
STER
-100
Closed -$3K
PETQ
3329
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-172
Closed -$4K
ASTSW
3330
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$0 ﹤0.01%
151
MKFG.WS
3331
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$0 ﹤0.01%
250
AMK
3332
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$0 ﹤0.01%
7
-1
-13% -$26
DNA.WS
3333
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
-400
Closed -$1K
MORF
3334
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-76
Closed -$4K
VBIV
3335
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$0 ﹤0.01%
+3
New +$253
CONN
3336
DELISTED
Conn's Inc.
CONN
-19
Closed
MCBC
3337
DELISTED
Macatawa Bank Corp
MCBC
$0 ﹤0.01%
31
CERE
3338
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$0 ﹤0.01%
+9
New +$318
BHIL
3339
DELISTED
Benson Hill, Inc.
BHIL
-29
Closed -$7K
DMTK
3340
DELISTED
DermTech, Inc. Common Stock
DMTK
-700
Closed -$22K
BIOL
3341
DELISTED
Biolase, Inc.
BIOL
0
THMO
3342
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
0
NURO
3343
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$0 ﹤0.01%
1
AFIB
3344
DELISTED
Acutus Medical Inc
AFIB
$0 ﹤0.01%
129
+117
+975% +$659
FIF
3345
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
$0 ﹤0.01%
1
NXTP
3346
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$0 ﹤0.01%
+1
New +$29
KNTE
3347
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
-199
Closed -$5K
PGTI
3348
DELISTED
PGT, Inc.
PGTI
-11
Closed
MIXT
3349
DELISTED
MIX TELEMATICS LIMITED
MIXT
-49
Closed -$1K
KRTX
3350
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$0 ﹤0.01%
+1
New +$129

Similar funds

Parallel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Parallel Advisors held 3,484 positions worth $2.69B, up 8.6% from $2.48B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q4 2021 filing shows 257 new, 1,490 increased, 872 reduced and 231 closed positions. Its largest new stake was Payoneer: 1,784,455 shares worth $13.1M. The largest sale was iShares US Treasury Bond ETF, an estimated $17.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q4 2021 buy was Payoneer: 1,784,455 shares worth $13.1M.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q4 2021, an estimated $29.6M increase.
  • Parallel Advisors's biggest Q4 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $17.7M.
  • Parallel Advisors fully exited FTAC Olympus Acquisition Corp. Class A Ordinary Shares in Q4 2021, selling an estimated $15.5M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.69B portfolio in Q4 2021.
  • Parallel Advisors opened 257 new positions and closed 231 in Q4 2021.
  • Parallel Advisors's portfolio value rose 8.6% quarter-over-quarter to $2.69B.

Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.